Evaluation Studies
Journal Article
Add like
Add dislike
Add to saved papers

Enantioseparation of Imazalil and Monitoring of Its Enantioselective Degradation in Apples and Soils Using Ultrahigh-Performance Liquid Chromatography-Tandem Mass Spectrometry.

Imazalil is a widely used systemic chiral fungicide that is still being employed as a racemic mixture without distinguishing the difference between enantiomers, which often leads to its inaccurate risk assessment. In this study, a robust and highly sensitive chiral separation method was developed for imazalil enantiomers by ultrahigh-performance liquid chromatography-tandem mass spectrometry and was further applied to study the degradation dynamics of imazalil enantiomers in apples and field soils at three sites in China. The baseline enantioseparation for imazalil was achieved within 3.5 min on a Lux Cellulose-2 (CCMPC) column with acetonitrile (ACN)/water (65:35, v/v) with a mobile phase at 0.5 mL/min flow rate and a column temperature of 20 °C. The limit of quantitation (LOQ) for each enantiomer was <0.60 μg/kg, with a baseline resolution of approximately 1.75. The research showed that (S)-(+)-imazalil degraded more rapidly than (R)-(-)-imazalil in Gala apples, whereas (R)-(-)-imazalil preferentially degraded in Golden Delicious apples. No significant enantioselectivity was observed in OBIR-2T-47 apples and field soils from the three sites. Results of this study provide useful references for risk assessment and the rational use of imazalil in further agricultural produce practice.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app